Keros Therapeutics, Inc.
KROS | US
Overview
Corporate Details
- ISIN(s):
- US4923271013
- LEI:
- Country:
- United States of America
- Address:
- 1050 WALTHAM STREET, SUITE 302, 2421 LEXINGTON
- Website:
- https://www.kerostx.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Keros Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for Keros Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Keros Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Developing ATO and cell therapies for autoimmune diseases and tissue regeneration.
Belgium
BIOS
Belgium
BIOS
Biotech group offering preclinical zebrafish testing & intein tech for human/animal health.
Spain
BST
Spain
BST
Develops blood tests to monitor the efficacy of solid tumor cancer therapies.
Sweden
BIOVIC
Sweden
BIOVIC
Develops cell therapies and tissue products for bone grafts and inflammation repair.
Israel
BONS
Israel
BONS
Develops custom enzymes and microbes for the food, nutrition, and chemical industries.
Germany
BNN
Germany
BNN
Develops off-the-shelf cellular immunotherapies for advanced breast, prostate, and lung cancers.
United States of America
BCTX
United States of America
BCTX
Biotech investor developing cell-based tissue solutions for food, materials, and health markets.
United Kingdom
BSFA
United Kingdom
BSFA
Leverages causal AI to accelerate drug discovery and identify novel targets for biopharmaceuticals.
United States of America
BFRG
United States of America
BFRG
Offers NGS-based diagnostics for precision oncology, from detection to clinical trial support.
United States of America
BNR
United States of America
BNR
Develops engineered T cell therapies for a curative reset in autoimmune diseases.
United States of America
CABA
United States of America
CABA